PM Anwar calls for stronger ASEAN research ties to reduce medical costs
KUALA LUMPUR: Prime Minister Datuk Seri Anwar Ibrahim has called on Clinical Research Malaysia (CRM) and other local medical research institutions to enhance collaboration with counterparts across ASEAN to help lower the cost of medicines, accelerate medical discoveries, and develop treatments tailored to the region's needs.
He stressed that CRM should also work closely with local universities, particularly medical faculties, to ensure research efforts are impactful and serve the needs of the people.
'One of our key challenges is to prevent healthcare costs from escalating. The medical industry can become burdensome, as we've seen major companies earning excessive profits without considering the burden on consumers,' he said at the official opening of the CRM Trial Connect Conference 2025 here today.
Anwar added that a stronger and more coordinated ASEAN collaboration, involving major research centres in Phnom Penh, Vientiane, Singapore, Jakarta, Bangkok, Manila and beyond, could pave the way for meaningful progress in clinical research.
Also present were Health Minister Datuk Seri Dr Dzulkefly Ahmad and Sarawak Deputy Premier Datuk Amar Dr Sim Kui Hian, who also serves as the state's Minister for Public Health, Housing and Local Government.
-- MORE
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
an hour ago
- Malay Mail
Smoking law breaches, unsafe food, and HFMD risks: Penang health sweep nets 167 notices, seven closures, including kindergarten
GEORGE TOWN, June 14 — The Penang state health department shut down seven premises, including a kindergarten, and issued 167 notices for various offences along with compounds worth RM43,600 in a public health operation Thursday. The operation was conducted to ensure compliance of the Control of Smoking Products for Public Health Act 2024 (Act 852), the Food Act 1983 (Act 281), the Destruction of Disease-Bearing Insects Act 1975 (Act 154 and the Prevention and Control of Infectious Diseases (Amendment) 2025 (Act 342). 'A total of 84 notices were issued with compounds worth RM20,600 for various offences under Act 852, and notices to appear in court for prosecution were issued for two offences for selling cigarettes in open packs and one offence for selling cigarettes under the sale price. 50 tobacco products worth RM179 were also seized,' the department said in a statement tonight. Also, 45 eateries were inspected with 68 notices issued with compounds worth RM14,500 issued under Act 281, with six premises ordered shut immediately and one grocery store issued a compound of RM2,500 for selling products that did not have manufacturer's information. In addition, 111 food products worth an estimated RM766.70 were seized. Finally, a total of 929 premises were inspected under Act 154 and 12 notices with compounds worth RM6,000 were issued, along with a clean up work order notice issued. A kindergarten was also ordered shut under Act 342 after being found to be at risk of spreading hand, foot, and mouth disease. — Bernama
Borneo Post
2 days ago
- Borneo Post
MoU to boost cancer care in Sabah
Dr Dzulkefly speaking to the media. KOTA KINABALU (June 12): A Memorandum of Understanding (MoU) was signed between Cancer Research Malaysia (CRM) and six hospitals in Sabah today to enhance cancer treatment and support services under the Pink Ribbon Programme, also known as the Enhanced Patient Navigation Programme. Federal Health Minister Datuk Seri Dr Dzulkefly Ahmad, who witnessed the signing, said the hospitals involved are the Women and Children's Hospital, Tawau Hospital, Duchess of Kent Hospital, Keningau Hospital, Beaufort Hospital and Kota Marudu Hospital. He described the programme as a major step forward in patient care, offering a system where cancer patients are continuously guided and monitored throughout their treatment journey. 'I was informed that the default rate used to be around 20%, but now it is almost zero, which means patients are complying with treatment and returning for follow-ups. This is an achievement we can be proud of,' Dr Dzulkefly told reporters at Queen Elizabeth Hospital II. He was present for the handing-over ceremony of 100 hemodialysis machines from the Sabah Government, represented by Community Development and People's Wellbeing Minister Datuk James Ratib, who is also responsible for health matters in the state. Dr Dzulkefly emphasized that the Pink Ribbon initiative goes beyond standard navigation systems, calling it an 'enhanced' service that has delivered excellent outcomes in preventing patients from defaulting on their treatments. In a separate development, Dr Dzulkefly also briefed the media on his earlier meeting with Chief Minister Datuk Seri Panglima Hajiji Noor. Describing it as a meaningful engagement, he said the discussion focused on the Malaysia Agreement 1963 (MA63) and included an explanation of five sub-committees addressing related issues. 'We presented our plans, recommendations, and proposals in detail, which were received by the Ministry of Health in Putrajaya and my ministry. One of the proposals includes a funding allocation of nearly RM4 billion for the year 2030,' he said. The goal, he added, is to close service delivery gaps across all 23 to 24 government hospitals in Sabah. He also revealed that discussions were held about lifting the freeze on rural doctors' allowances in Sabah and Sarawak. 'That issue was raised, and we are taking it seriously. We will table it at the upcoming post-cabinet meeting for further discussion and follow-up. I'm confident it will be given due consideration,' he said. In addition, Dr Dzulkefly addressed developments concerning the proposed upgrade of the Heart Centre at Queen Elizabeth Hospital II. He confirmed that preliminary work has begun, and discussions are ongoing, including land matters raised by the Chief Minister. 'We still have several key objectives to meet, but we are committed to doing our best, God willing,' he said.
Malay Mail
4 days ago
- Malay Mail
First vape, next cake? The slippery slope of selective bans — Sim Tian Hong
JUNE 10 — The recent calls for a nationwide vape ban have been hogging the headlines. Just recently, Segamat MP R. Yuneswaran urged the Federal government to impose a blanket ban, citing rising healthcare costs and increasing youth vaping rates. Meanwhile, states such as Selangor, Kelantan, Johor, Negeri Sembilan and Terengganu have already moved ahead with bans of their own or are debating similar measures. These moves are driven by understandable public health concerns. No one is questioning the motivations behind such calls. After all, nothing is more important than public health. However, are we approaching this issue in a consistent and coherent way? If we are banning vape to protect public health, why are cigarettes — a product known to cause cancer, heart disease, and countless other illnesses — still legally sold and taxed? According to the Ministry of Health, tobacco use remains one of the most preventable causes of death in Malaysia. Yet, while vape is being banned or restricted in piecemeal fashion, cigarettes remain a fixture in convenience stores nationwide. The recent calls for a nationwide vape ban have been hogging the headlines. — Picture by Raymond Manuel This inconsistency becomes even more troubling when one considers the fragmented nature of the current policy response. Some states are imposing their own bans, others are not. The Federal government has yet to adopt a clear, unified stance. The result is a patchwork of differing rules across the country. This is bound to create confusion for the public, enforcement challenges for authorities, and opportunities for an illicit market to flourish. There is also the risk of setting a questionable policy precedent. If the principle is that we should ban products that can harm public health, where do we draw the line? Should we also move to ban junk food, sugary drinks, or alcohol, all of which contribute to non-communicable diseases and healthcare costs? I am not suggesting that we ignore the risks associated with vaping. But we should be wary of making selective, reactive policy decisions that are not grounded in a consistent framework. Rather than imposing outright bans in an uneven and fragmented way, there is a case for a more balanced and coherent approach. Stronger public education campaigns, tighter regulation of marketing and sales (especially to minors), and consistent enforcement across states may ultimately prove more effective than prohibition alone. Above all, public health policy should be seen as fair, rational, and consistent. A strategy that appears to single out certain products while ignoring others with well-documented harms, risks undermining public trust. It may also distract from the broader effort to build a healthier society. Public health must always come first. But in pursuing that goal, we should avoid the temptation to adopt inconsistent or populist measures that may generate headlines, but not necessarily better outcomes. * This is the personal opinion of the writer or publication and does not necessarily represent the views of Malay Mail.
